Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: Illustration of complexity in molecular diagnostic interpretation

Jamie McDonald, Friederike Gedge, Allene Burdette, James Carlisle, Changkuoth Jock Bukjiok, Michelle Fox, Pinar Bayrak-Toydemir

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Hereditary hemorrhagic telangiectasia is an autosomal dominant disease caused by mutations in the ACVRL1 and ENG genes characterized by arterio-venous malformations and telangiectases. Over 700 mutations have been described in these two genes, and missense mutations are common. We describe 10 cases in which more than one potentially pathogenic mutation was identified. We report that 8 novel missense mutations, as well as previously reported pathogenic missense mutations, were seen in combination with a second mutation, which raises questions with regards to their respective pathogenicity. Our data and discussion indicate the challenges of classifying missense mutations as pathogenic or benign and the value of co-segregation studies, as well as suggest that there may be hereditary hemorrhagic telangiectasia gene mutations that have only mild phenotypic effects. We present evidence to suggest that four missense mutations (ENG p.G331S, ENG p.L8P, ENG p.P452L and ACVRL1 p.C344R) are pathogenic, two novel mutations (ACVRL1 p.A311T and ENG p.S576G) are neutral, and two previously reported disease-causing mutations are benign or have suspected benign variants (ACVRL1 p.A482V and ENG p.V504M). We conclude that for the purpose of establishing a causative hereditary hemorrhagic telangiectasia mutation in a family proband, all exons and intron/exon borders of both genes should be sequenced and deletion/duplication analysis should be performed unless a mutation that is well-proven to be pathogenic is identified.

Original languageEnglish (US)
Pages (from-to)569-575
Number of pages7
JournalJournal of Molecular Diagnostics
Volume11
Issue number6
DOIs
StatePublished - Nov 2009

Fingerprint

Hereditary Hemorrhagic Telangiectasia
Molecular Pathology
Mutation
Missense Mutation
Genes
Exons
Telangiectasis
Introns
Virulence

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Medicine

Cite this

McDonald, Jamie ; Gedge, Friederike ; Burdette, Allene ; Carlisle, James ; Bukjiok, Changkuoth Jock ; Fox, Michelle ; Bayrak-Toydemir, Pinar. / Multiple sequence variants in hereditary hemorrhagic telangiectasia cases : Illustration of complexity in molecular diagnostic interpretation. In: Journal of Molecular Diagnostics. 2009 ; Vol. 11, No. 6. pp. 569-575.
@article{6bb50f474bdd42d29720b263ff998777,
title = "Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: Illustration of complexity in molecular diagnostic interpretation",
abstract = "Hereditary hemorrhagic telangiectasia is an autosomal dominant disease caused by mutations in the ACVRL1 and ENG genes characterized by arterio-venous malformations and telangiectases. Over 700 mutations have been described in these two genes, and missense mutations are common. We describe 10 cases in which more than one potentially pathogenic mutation was identified. We report that 8 novel missense mutations, as well as previously reported pathogenic missense mutations, were seen in combination with a second mutation, which raises questions with regards to their respective pathogenicity. Our data and discussion indicate the challenges of classifying missense mutations as pathogenic or benign and the value of co-segregation studies, as well as suggest that there may be hereditary hemorrhagic telangiectasia gene mutations that have only mild phenotypic effects. We present evidence to suggest that four missense mutations (ENG p.G331S, ENG p.L8P, ENG p.P452L and ACVRL1 p.C344R) are pathogenic, two novel mutations (ACVRL1 p.A311T and ENG p.S576G) are neutral, and two previously reported disease-causing mutations are benign or have suspected benign variants (ACVRL1 p.A482V and ENG p.V504M). We conclude that for the purpose of establishing a causative hereditary hemorrhagic telangiectasia mutation in a family proband, all exons and intron/exon borders of both genes should be sequenced and deletion/duplication analysis should be performed unless a mutation that is well-proven to be pathogenic is identified.",
author = "Jamie McDonald and Friederike Gedge and Allene Burdette and James Carlisle and Bukjiok, {Changkuoth Jock} and Michelle Fox and Pinar Bayrak-Toydemir",
year = "2009",
month = "11",
doi = "10.2353/jmoldx.2009.080148",
language = "English (US)",
volume = "11",
pages = "569--575",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "6",

}

Multiple sequence variants in hereditary hemorrhagic telangiectasia cases : Illustration of complexity in molecular diagnostic interpretation. / McDonald, Jamie; Gedge, Friederike; Burdette, Allene; Carlisle, James; Bukjiok, Changkuoth Jock; Fox, Michelle; Bayrak-Toydemir, Pinar.

In: Journal of Molecular Diagnostics, Vol. 11, No. 6, 11.2009, p. 569-575.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multiple sequence variants in hereditary hemorrhagic telangiectasia cases

T2 - Illustration of complexity in molecular diagnostic interpretation

AU - McDonald, Jamie

AU - Gedge, Friederike

AU - Burdette, Allene

AU - Carlisle, James

AU - Bukjiok, Changkuoth Jock

AU - Fox, Michelle

AU - Bayrak-Toydemir, Pinar

PY - 2009/11

Y1 - 2009/11

N2 - Hereditary hemorrhagic telangiectasia is an autosomal dominant disease caused by mutations in the ACVRL1 and ENG genes characterized by arterio-venous malformations and telangiectases. Over 700 mutations have been described in these two genes, and missense mutations are common. We describe 10 cases in which more than one potentially pathogenic mutation was identified. We report that 8 novel missense mutations, as well as previously reported pathogenic missense mutations, were seen in combination with a second mutation, which raises questions with regards to their respective pathogenicity. Our data and discussion indicate the challenges of classifying missense mutations as pathogenic or benign and the value of co-segregation studies, as well as suggest that there may be hereditary hemorrhagic telangiectasia gene mutations that have only mild phenotypic effects. We present evidence to suggest that four missense mutations (ENG p.G331S, ENG p.L8P, ENG p.P452L and ACVRL1 p.C344R) are pathogenic, two novel mutations (ACVRL1 p.A311T and ENG p.S576G) are neutral, and two previously reported disease-causing mutations are benign or have suspected benign variants (ACVRL1 p.A482V and ENG p.V504M). We conclude that for the purpose of establishing a causative hereditary hemorrhagic telangiectasia mutation in a family proband, all exons and intron/exon borders of both genes should be sequenced and deletion/duplication analysis should be performed unless a mutation that is well-proven to be pathogenic is identified.

AB - Hereditary hemorrhagic telangiectasia is an autosomal dominant disease caused by mutations in the ACVRL1 and ENG genes characterized by arterio-venous malformations and telangiectases. Over 700 mutations have been described in these two genes, and missense mutations are common. We describe 10 cases in which more than one potentially pathogenic mutation was identified. We report that 8 novel missense mutations, as well as previously reported pathogenic missense mutations, were seen in combination with a second mutation, which raises questions with regards to their respective pathogenicity. Our data and discussion indicate the challenges of classifying missense mutations as pathogenic or benign and the value of co-segregation studies, as well as suggest that there may be hereditary hemorrhagic telangiectasia gene mutations that have only mild phenotypic effects. We present evidence to suggest that four missense mutations (ENG p.G331S, ENG p.L8P, ENG p.P452L and ACVRL1 p.C344R) are pathogenic, two novel mutations (ACVRL1 p.A311T and ENG p.S576G) are neutral, and two previously reported disease-causing mutations are benign or have suspected benign variants (ACVRL1 p.A482V and ENG p.V504M). We conclude that for the purpose of establishing a causative hereditary hemorrhagic telangiectasia mutation in a family proband, all exons and intron/exon borders of both genes should be sequenced and deletion/duplication analysis should be performed unless a mutation that is well-proven to be pathogenic is identified.

UR - http://www.scopus.com/inward/record.url?scp=70350453921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350453921&partnerID=8YFLogxK

U2 - 10.2353/jmoldx.2009.080148

DO - 10.2353/jmoldx.2009.080148

M3 - Article

C2 - 19767588

AN - SCOPUS:70350453921

VL - 11

SP - 569

EP - 575

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 6

ER -